Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Linde PLC (LIN) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Linde PLC vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Linde PLC trades at $483.73 (market cap $222.05B), while Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B). The key difference: Linde PLC is far larger — about 127.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Linde PLC pays a 1.33% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Linde PLC for 88 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.

LINNUVB
Market Cap
$222.05B$1.74B
Volume
2,116,4409,289,619
Sector
Basic MaterialsHealth
52-Week High
$546.64$9.54
52-Week Low
$389.38$3.41
Typical Hold Time
88 Days1 Days
Enterprise Value
$245.17B$1.33B
Dividend Yield
1.33%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Linde PLC

Linde (LIN) trades at $481.70, down 0.47% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $4.50 beating estimates of $4.49, and maintains healthy profitability with a 20.43% net income margin. Analyst sentiment remains overwhelmingly positive with 89.66% buy ratings and a $557.10 consensus price target representing 15.6% upside potential from current levels.

The outlook remains favorable given Linde's leadership in industrial gases and exposure to AI chip manufacturing growth, though valuation at 31.08 P/E requires continued execution. Key risks include margin pressure from higher capital expenditures and competitive dynamics in the electronics sector. The stock's technical setup suggests support near $479 with resistance at $485, providing clear levels for near-term price action.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LIN
0% Buy100% Sell
Avg holding period · 88 Days
NUVB

No sentiment data available yet.

About Linde PLC

Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.

Read more on LIN →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →